BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31750328)

  • 1. Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients.
    Zhao SR; Ni XM; Zhang XA; Tian H
    World J Clin Cases; 2019 Nov; 7(21):3446-3462. PubMed ID: 31750328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM; Chalder T; McCrone P; Darnley S; Knapp M; Jones RH; Wessely S
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Owusu JT; Sibelli A; Moss-Morris R; van Tilburg MAL; Levy RL; Oser M
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14108. PubMed ID: 33745228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M; Miguez S; Dukas B; Onwude O; White S
    JMIR Mhealth Uhealth; 2021 May; 9(5):e26152. PubMed ID: 33872182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Geng LL; Huang H; Xuan YC; Wan JW; Yu XJ; Nie XF; Hu XW
    Zhongguo Zhen Jiu; 2023 Sep; 43(9):1028-32. PubMed ID: 37697878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with
    Guo J; Sun JH; Chen L; Geng H; Yang GH; Shen RR; Ding M; Lu J; Liu L; Fang XD; Pei LX
    Zhongguo Zhen Jiu; 2021 Aug; 41(8):845-50. PubMed ID: 34369692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between curative effect and 5-HTTLPR polymorphism in treatment of diarrhea-predominant irritable bowel syndrome with acupuncture for regulating
    Guo J; Sun JH; Chen L; Geng H; Wu XL; Song YF; Yang GH; Shen RR; Ding M; Lu J; Liu L; Fang XD; Pei LX
    Zhongguo Zhen Jiu; 2021 Apr; 41(4):365-70. PubMed ID: 33909354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA; Landau S; O'Reilly G; Sibelli A; Hughes S; Windgassen S; Holland R; Little P; McCrone P; Bishop FL; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):863-872. PubMed ID: 31492643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
    Shi H; Niu Y; Huang Q; Yang ZM; Yang L
    Zhongguo Zhen Jiu; 2021 Sep; 41(9):984-90. PubMed ID: 34491647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.
    Zhao JM; Wu LY; Liu HR; Hu HY; Wang JY; Huang RJ; Shi Y; Tao SP; Gao Q; Zhou CL; Qi L; Ma XP; Wu HG
    World J Gastroenterol; 2014 Oct; 20(37):13563-72. PubMed ID: 25309087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis.
    Radu M; Moldovan R; Pintea S; Băban A; Dumitrascu D
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):257-263. PubMed ID: 30240469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and dose response of
    Martoni CJ; Srivastava S; Damholt A; Leyer GJ
    World J Gastroenterol; 2023 Jul; 29(28):4451-4465. PubMed ID: 37576702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herbal-moxa plaster for diarrhea type irritable bowel syndrome of spleen and kidney
    Zhao ZR; Wang YX; Xu FY; Zhang WC; Wang QY; Huang W
    Zhongguo Zhen Jiu; 2023 Jun; 43(6):617-21. PubMed ID: 37313553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
    Xu X; Liu L; Yao S; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome.
    Sugaya N; Tomita Y; Funaba M; Iida H; Shirotsuki K; Gardner FC; Odawara T; Ando T; Inamori M
    Biopsychosoc Med; 2022 Jul; 16(1):15. PubMed ID: 35871011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.